Provides the instruments, reagents and supplies, validated and approved for use by human leukocyte antigen (HLA) lab accrediting agency / american society of histocompatibility and immunogenetics…

Active Purchase Order Awarded Last action

Contract number
HT001426PE155
Awardee
Awarding agency
Obligated
$31,165

Award facts

Contract value 100% obligated
$31,165.13 Current and potential, with all options
Completion date 24% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20889, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a purchase order to Illumina, Inc. valued at $31,165.13 on July 24, 2026, for instruments, reagents, and supplies validated and approved for use by the Human Leukocyte Antigen (HLA) Lab Accrediting Agency and the American Society of Histocompatibility and Immunogenetics (ASHI). Work is performed in Bethesda, Maryland. The order carries a firm fixed price and an ultimate completion date of July 23, 2027.

Description

Provides the instruments, reagents and supplies, validated and approved for use by human leukocyte antigen (HLA) lab accrediting agency / american society of histocompatibility and immunogenetics (ashi).

Quick answers

Who was awarded contract HT001426PE155?

HT001426PE155 was awarded to Illumina, Inc. by Defense Health Agency (Department of Defense) on July 24, 2026.

How much is contract HT001426PE155 worth?

The government has obligated $31,165 on HT001426PE155.

Was contract HT001426PE155 competed?

The extent of competition for HT001426PE155 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award